Alcohol may hasten the progression of cancer

May 15, 2002

Alcohol, the socially acceptable drug, acts upon virtually every organ system and causes a variety of physiologic and behavioral alterations. Its ability to compromise the body's immune system has been linked to the development of infectious diseases such as tuberculosis, as well as oral cancer (including the oral cavity, pharynx, larynx, and oesophagus), liver cancer, and possibly breast cancer in women. A study in the May issue of Alcoholism: Clinical & Experimental Research (ACER) has found that individuals with cancer who drink excessively may be placing themselves at risk of a more rapid death from cancer.

"Some studies have shown that alcohol consumption increases cancer metastasis," said Gary G. Meadows, Director of the Cancer Prevention & Research Center at Washington State University, "while other studies have shown that alcohol consumption decreases metastasis. Thus, there is a lot more work needed in this area." Meadows, the Dorothy O. Kennedy Distinguished Professor, is also the corresponding author for the study.

For the May ACER study, pathogen-free female mice were divided into a number of study groups, each containing 20 mice. These included nontumor, water-consuming (NW) mice; nontumor, alcohol-consuming (NE) mice; with-tumor, water-consuming (TW) mice; with-tumor, alcohol-consuming (TE) mice; with-tumor, pair-fed mice that had their alcohol calories replaced with maltose-dextrin (T-PF); and with-tumor, pair-fed mice that did not have their alcohol-derived calories replaced with maltose-dextrin. The mice were given water or 20% w/v alcohol in their drinking water for three weeks to six months. Some were then inoculated with melanoma cells subcutaneously into the right dorsal hip. The mice continued to consume water or alcohol, and researchers gathered a variety of biochemical data at various time periods following tumor inoculation, as well as body weight, body water content, tumor weight, and carcass fat content.

"Alcohol consumption caused a loss in body fat in the mice with melanoma," said Meadows, "and this was associated with a decrease in survival of the melanoma-bearing mice. This could be important because cancer patients often lose a lot of weight near the end of life even if they are able to maintain their food intake. It is commonly thought that this weight loss accelerates the progression of the cancer and shortens survival. The weight loss for cancer patients is in body protein as well as body fat. However, the interesting thing about the loss of body weight in our study is that it was from fat, not protein."

"Although often regarded as socially unacceptable, fat serves a useful purpose as energy storage for the body," said Carl Waltenbaugh, professor of immunology at Northwestern University Medical School. "Chronic alcohol consumption increases leptin, a fat-cell (adipocyte) derived hormone that has multiple biological effects, including the ability to change lipid metabolism. Eventually, an alcoholic's body utilizes fat as a primary energy source, resulting in 'wasting' or rapid loss of body weight. Once fat reserves are exhausted, the body must rely more and more upon alcohol as an energy source. At the same time, alcohol depresses immune function, especially natural killer cells that are responsible for tumor cell elimination. This study shows that chronic alcohol consumption shortens cancer survival time for tumor-bearing patients. For alcoholics without known cancer, loss of natural killer cells means that a first line of defense is missing in these individuals, thus increasing their susceptibility to cancer in the future.

Waltenbaugh suggested that future research determine if alcohol presents a confounding factor for more cancers than melanoma; what amount and duration of alcohol consumption causes this effect; whether or not abstinence from alcohol might affect tumor progression/weight loss; and if leptin antagonists might increase chances of survival.

"Other studies have shown that abnormal leptin levels also alter immune function," he said. "Yet alcohol-induced augmentation of leptin is new to science. Elevated leptin levels and diminished immune function in alcohol-consuming individuals suggest a potential cause for increased susceptibility to infection in these individuals." Conversely, he said, this association may also allow scientists to develop ways to protect alcoholics from infection.

Another possibility for future leptin research, according to Meadows, is related to the finding that the tumor-bearing mice lost weight and fat without losing muscle mass (body protein).

"We are planning more studies in the future to see how alcohol influences fat metabolism," said Meadows. "We are very interested in finding the mechanism for the fat loss in the tumor-bearing mice, because this could lead to a new way to promote fat loss in obese people without the accompanying loss in muscle mass during dieting. In particular, we are interested in the effects that alcohol has on leptin, which also has a role in controlling obesity."
-end-
Co-authors of the Alcoholism: Clinical & Experimental Research paper included: Nomelí P. Núñez of the Department of Pharmaceutical Sciences, the Pharmacology and Toxicology Graduate Program, and the Cancer Prevention & Research Center at Washington State University; and Patrick A. Carter of the School of Biological Sciences at Washington State University. The study was funded by the National Institute on Alcohol Abuse and Alcoholism.

Alcoholism: Clinical & Experimental Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.